# CST2

## Overview
The CST2 gene encodes cystatin SA, a member of the cystatin superfamily, which functions as a cysteine protease inhibitor. This protein is primarily expressed in the parotid and submandibular glands and is present in human saliva, where it plays a significant role in oral health by inhibiting proteolytic enzymes such as cathepsins. Cystatin SA is categorized as a type 2 cystatin and is characterized by its ability to form a wedge-shaped structure that effectively inhibits protease activity. Beyond its role in oral health, CST2 is involved in modulating immune responses and has been implicated in various pathological conditions, including cancer and inflammatory diseases. The gene's expression and the protein's interactions with proteases are critical for maintaining cellular homeostasis and have potential therapeutic implications (Dickinson2002Expression; Zhang2023Type).

## Structure
Cystatin SA, encoded by the CST2 gene, is a type 2 cystatin characterized by a specific molecular structure. The primary structure of cystatin SA includes a conserved G-QXVXG-VPW sequence crucial for its function as a protease inhibitor (Zhang2023Type). The secondary structure consists of one alpha helix and five beta sheets, with four of these beta sheets arranged in an antiparallel form that covers the alpha helix (Zhang2023Type). This arrangement contributes to the protein's ability to inhibit cathepsins by forming a wedge-shaped structure that binds to the V-shaped cleft of cathepsins, effectively masking their active site (Zhang2023Type).

Cystatin SA has two known allele variants, SA1 and SA2, which differ by two amino acids. The SA2 variant is a weaker protease inhibitor due to a G79D polymorphism within the conserved QXVXG fragment (Zhang2023Type). The tertiary structure is stabilized by disulfide bridges, typical of cystatins, which help maintain its inhibitory conformation (Lupi2003Identification). The protein is expressed in the parotid and submandibular glands, playing a role in oral health by inhibiting proteolytic events and exhibiting antimicrobial functions (Zhang2023Type).

## Function
The CST2 gene encodes cystatin SA, a member of the SD-type cystatins, which are cysteine protease inhibitors primarily active in the extracellular spaces of the human body. These proteins are expressed in the parotid and submandibular glands and are found in human saliva, where they play a crucial role in maintaining oral health by inhibiting proteolytic events induced by cathepsins B, H, and L. This inhibition is essential for preventing periodontal tissue destruction and bacterial colonization, which can lead to periodontal disease (Zhang2023Type).

Cystatin SA also exhibits antimicrobial properties by inhibiting the growth of various bacterial strains, such as Aggregatibacter actinomycetemcomitans, Streptococcus pyogenes, and Porphyromonas gingivalis. The exact mechanism of this antimicrobial activity is not fully understood but may involve the inhibition of proteolytic activity necessary for bacterial growth (Zhang2023Type).

In addition to its role in oral health, CST2 is involved in modulating the immune response. It may provide specific inhibition of certain enzymes involved in tissue breakdown and invasion during inflammation and cancer, thereby contributing to the regulation of immune responses and protection of epithelial surfaces (Dickinson2002Expression).

## Clinical Significance
CST2, also known as cystatin SA, is implicated in various diseases due to its role in regulating proteolytic events. Alterations in CST2 expression have been associated with cancer progression, particularly in prostate and gastric cancers, where its upregulation correlates with tumor metastasis. CST2 may influence tumorigenesis by regulating the TGF-β signaling pathway and promoting epithelial-mesenchymal transition (EMT), although the precise mechanisms remain to be fully elucidated (Zhang2023Type).

In the context of hepatitis B virus-related hepatocellular carcinoma (HBV-related HCC), CST2 is one of several cystatin genes with increased expression in tumor tissues compared to normal tissues. This differential expression suggests a potential role in the disease's pathology, although specific mutations or interaction changes in CST2 were not detailed in the study (Zhou2019Investigation).

CST2 is also noted as a clinical biomarker for allergic respiratory diseases, such as asthma and chronic rhinosinusitis, due to its involvement in immune response regulation. However, the detailed mechanisms of its immune regulatory function and the clinical significance of CST2 gene mutations or expression changes in these conditions are not fully understood (Zhang2023Type).

## Interactions
CST2, or cystatin SA, is known to interact with cysteine proteases, particularly cathepsins, to regulate their activity. These interactions are crucial for maintaining the balance of proteolytic activity within the extracellular matrix. By inhibiting cathepsins, CST2 plays a role in modulating processes such as inflammation and immune response. The protein-protein interactions involving CST2 are significant in controlling the degradation of extracellular matrix components, which can influence tissue remodeling and repair. These interactions may also have implications in pathological conditions where protease activity is dysregulated, such as in certain inflammatory diseases. The ability of CST2 to participate in these interactions highlights its importance in maintaining cellular homeostasis and its potential role in therapeutic interventions targeting protease activity.


## References


[1. (Dickinson2002Expression) D.P. Dickinson, M. Thiesse, and M.J. Hicks. Expression of type 2 cystatin genescst1-cst5in adult human tissues and the developing submandibular gland. DNA and Cell Biology, 21(1):47–65, January 2002. URL: http://dx.doi.org/10.1089/10445490252810311, doi:10.1089/10445490252810311. This article has 49 citations and is from a peer-reviewed journal.](https://doi.org/10.1089/10445490252810311)

[2. (Zhou2019Investigation) Xin Zhou, Xiangkun Wang, Ketuan Huang, Xiwen Liao, Chengkun Yang, Tingdong Yu, Junqi Liu, Chuangye Han, Guangzhi Zhu, Hao Su, Wei Qin, Quanfa Han, Zhengqian Liu, Jianlv Huang, Yizhen Gong, Xinping Ye, and Tao Peng. Investigation of the clinical significance and prospective molecular mechanisms of cystatin genes in patients with hepatitis b virus‑related hepatocellular carcinoma. Oncology Reports, May 2019. URL: http://dx.doi.org/10.3892/or.2019.7154, doi:10.3892/or.2019.7154. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/or.2019.7154)

[3. (Lupi2003Identification) Alessandro Lupi, Irene Messana, Gloria Denotti, Maria Eugenia Schininà, Gianluca Gambarini, Maria Benedetta Fadda, Alberto Vitali, Tiziana Cabras, Vincenzo Piras, Maria Patamia, Massimo Cordaro, Bruno Giardina, and Massimo Castagnola. Identification of the human salivary cystatin complex by the coupling of high‐performance liquid chromatography and ion‐trap mass spectrometry. PROTEOMICS, 3(4):461–467, March 2003. URL: http://dx.doi.org/10.1002/pmic.200390060, doi:10.1002/pmic.200390060. This article has 49 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/pmic.200390060)

[4. (Zhang2023Type) Zijun Zhang and Fenghuang Zhan. Type 2 cystatins and their roles in the regulation of human immune response and cancer progression. Cancers, 15(22):5363, November 2023. URL: http://dx.doi.org/10.3390/cancers15225363, doi:10.3390/cancers15225363. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers15225363)